Literature DB >> 24604613

FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4'-di-n-octyl genistein.

Yingxia Ning1, Chaoyuan Luo2, Kaiqun Ren3, Meifang Quan3, Jianguo Cao3.   

Abstract

Carcinogenesis is predominantly dependent on the cancer stem cells (CSCs) residing or populating within the cancer. We previously demonstrated that the novel synthetic genistein analogue, 7-difluoromethoxyl-5,4'-di-n-octylgenistein (DFOG), induced apoptotic cell death of ovarian and gastric cancer cells. The present study demonstrated that sphere‑forming cells (SFCs) derived from the ovarian cancer cell-line SKOV3 possessed ovarian cancer stem-like cell (OCSLC) properties, including self-renewal and high tumorigenicity. DFOG may be effective in inhibiting the self‑renewal capacity of SFCs derived from the SKOV3 cell line. DFOG decreased the level of phosphorylated FOXO3a protein in SKOV3 cell‑derived SFCs. The inhibition of FOXO3a expression by siRNA significantly attenuated the ability of DFOG to inhibit the self-renewal capacity of SKOV3-derived SFCs. Our results suggested that DFOG has been demonstrated to significantly inhibit the self-renewal capacity of ovarian cancer stem cells (OCSCs) through a mechanism partly dependent on the activation of FOXO3a.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24604613     DOI: 10.3892/mmr.2014.2012

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  11 in total

1.  FOXO3a: A Potential Target in Prostate Cancer.

Authors:  Sanjeev Shukla
Journal:  Austin J Urol       Date:  2014

2.  Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc.

Authors:  Ying-Xia Ning; Xin Luo; Meng Xu; Xin Feng; Jian Wang
Journal:  Oncotarget       Date:  2017-08-23

Review 3.  Tumor evolution and chemoresistance in ovarian cancer.

Authors:  Soochi Kim; Youngjin Han; Se Ik Kim; Hee-Seung Kim; Seong Jin Kim; Yong Sang Song
Journal:  NPJ Precis Oncol       Date:  2018-09-17

4.  Drug-target-disease network analysis of gene-phenotype connectivity for genistein in ovarian cancer.

Authors:  Chen Zhang; Fan Yang; Suiqin Ni; Wenbing Teng; Yingxia Ning
Journal:  Onco Targets Ther       Date:  2018-12-10       Impact factor: 4.147

Review 5.  Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications.

Authors:  Francesca Nazio; Matteo Bordi; Valentina Cianfanelli; Franco Locatelli; Francesco Cecconi
Journal:  Cell Death Differ       Date:  2019-02-06       Impact factor: 15.828

6.  Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low-dose fraction radiation.

Authors:  Lili Zhao; Shihai Liu; Donghai Liang; Tao Jiang; Xiaoyan Yan; Shengnan Zhao; Yuanwei Liu; Wei Zhao; Hongsheng Yu
Journal:  Cancer Med       Date:  2019-04-02       Impact factor: 4.452

Review 7.  The Great Escape: The Power of Cancer Stem Cells to Evade Programmed Cell Death.

Authors:  Vanessa Castelli; Antonio Giordano; Elisabetta Benedetti; Francesco Giansanti; Massimiliano Quintiliani; Annamaria Cimini; Michele d'Angelo
Journal:  Cancers (Basel)       Date:  2021-01-17       Impact factor: 6.639

Review 8.  Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies.

Authors:  Mahshid Deldar Abad Paskeh; Shafagh Asadi; Amirhossein Zabolian; Hossein Saleki; Mohammad Amin Khoshbakht; Sina Sabet; Mohamad Javad Naghdi; Mehrdad Hashemi; Kiavash Hushmandi; Milad Ashrafizadeh; Sepideh Mirzaei; Ali Zarrabi; Gautam Sethi
Journal:  Int J Mol Sci       Date:  2021-10-28       Impact factor: 5.923

9.  An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.

Authors:  Linda Smit; Katrien Berns; Katherine Spence; W David Ryder; Nik Zeps; Mandy Madiredjo; Roderick Beijersbergen; René Bernards; Robert B Clarke
Journal:  Oncotarget       Date:  2016-01-19

10.  Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells.

Authors:  Heejin Lee; Jun Woo Kim; Dae Kyung Kim; Dong Kyu Choi; Seul Lee; Ji Hoon Yu; Oh-Bin Kwon; Jungsul Lee; Dong-Seok Lee; Jae Ho Kim; Sang-Hyun Min
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.